Pharmaceutical and healthcare: DTC prescription prod...

 

Previous pageNext pagePage 1 of 2


all[57]papers[36]cases[18]news[0]classics[3]
Sort by:
 Date      Most read
Narrow by:
Search within results:
Start searching...
Reset search
Print  |  Email  |  Add to My Folder
My preferred format is HTML  |  Change to PDF

Paper
1.
Consumer responses towards non-prescription and prescription drug advertising in the US and Germany: they don't really like it, but they do believe it
Sandra Diehl, Barbara Mueller and Ralf Terlutter, International Journal of Advertising, Vol. 27, No. 1, 2008, pp.99-131
Pharmaceutical advertising has generated considerable interest among both researchers and practitioners. This paper analyses overall attitude and scepticism towards both nonprescription and prescripti ...

Summary | Full Text | More Like This
Read: 48 times
Paper
2.
Direct-to-Consumer Pharmaceutical Advertising: Building and Testing a Model for Advertising Effectiveness
Rick T. Wilson and Brian D. Till, Journal of Advertising Research, Vol. 47, No. 3, Sept 2007, pp.270-282
Using a large-scale database, we present, test, and refine a model for direct-to-consumer (DTC) advertising effectiveness via structural equation modeling. Results suggest that consumers who are great ...

Summary | Full Text | More Like This
Read: 44 times
Award-winning case study
3.
Rozerem: Your Dreams Miss You
New York American Marketing Association, Silver, Healthcare (Rx), EFFIE Awards 2007
Rozerem – the first innovation in sleep medicines in nearly 35 years – launched in a highly competitive environment. The goal was to cut through the clutter –- seeding the idea in sleep sufferers' min ...

Summary | Full Text | More Like This
Read: 68 times
Case Study
4.
Sanofi-Aventis: Spirit Of Freedom campaign
William Baue, Encyclopedia of Major Marketing Campaigns, Gale, Volume 2, 2007, pp.1461-1464
On August 8, 1997, the United States Food and Drug Administration (FDA) announced new guidelines regulating direct-to-consumer (DTC) advertising of prescription drugs. The following Monday Hoechst Mar ...

Summary | Full Text | More Like This
Read: 44 times
Case Study
5.
Pfizer Inc.: The Power Of Zyrtec campaign
Susan Risland, Encyclopedia of Major Marketing Campaigns, Gale, Volume 2, 2007, pp.1311-1328
Pfizer Inc. emphasized the strength of Zyrtec, a prescription antihistamine, with surreal advertisements that showed people fleeing from allergy-inducing animals and flowers, then taking Zyrtec and re ...

Summary | Full Text | More Like This
Read: 48 times
Case Study
6.
Pfizer Inc.: Viagra Launch campaign
Mark Lane, Encyclopedia of Major Marketing Campaigns, Gale, Volume 2, 2007, pp.1311-1328
In March 1998 Pfizer Inc., the world's largest research-based pharmaceutical company, won FDA approval of its anti-impotency drug, Viagra. Because of the nature of the condition it was meant ...

Summary | Full Text | More Like This
Read: 113 times
Case Study
7.
Novartis AG: Tummies campaign
Mark Lane, Encyclopedia of Major Marketing Campaigns, Gale, Volume 2, 2007, pp.1209-1212
At the turn of the millennium pharmaceutical giant Novartis AG of Switzerland boasted a wide range of products, including one of the industry's most promising stables of prescription drugs awai ...

Summary | Full Text | More Like This
Read: 42 times
Case Study
8.
GlaxoSmithKline plc: Social Anxiety Disorder campaign
Mark Lane, Encyclopedia of Major Marketing Campaigns, Gale, Volume 2, 2007, pp.661-668
In 1999 Paxil, manufactured by SmithKline Beecham (now GlaxoSmithKline plc), was third among the pharmaceutical industry's best-selling SSRIs, a class of drugs then used primarily to treat de ...

Summary | Full Text | More Like This
Read: 55 times
Case Study
9.
Eli Lilly and Company: Prozac Print campaign
Rebecca Stanfel, Encyclopedia of Major Marketing Campaigns, Gale, Volume 2, 2007, pp.505-508
Since its introduction in 1987, Prozac's sales had boomed, generating significant revenue for its manufacturer Eli Lilly and Company. But the success of this new type of antidepressant—a ...

Summary | Full Text | More Like This
Read: 41 times
Award-winning case study
10.
Sanofi Aventis (Italy) - YOUnique
Integrated Marketing Communications Council Europe, Bronze, PMC European Awards 2006
The pharmaceutical company Sanofi Aventis wanted to develop a loyalty programme for pharmacists, called the “YOUnique club”, so that pharmacists could accumulate points to have access to prizes releva ...

Summary | Full Text | More Like This
Read: 51 times
Paper
11.
Taking the cost out of R&D and researching again
Bob Leitman, ESOMAR, Healthcare Conference, New York, February 2006
As consumer healthcare costs escalate, the pharmaceutical industry continues to lose consumer trust. Pharmaceutical companies can reduce consumers' drug costs as a route to improving the industry's im ...

Summary | Full Text | More Like This
Read: 20 times
Paper
12.
Semiotic codes in the pharmaceutical industry - borrowing from FMCG and other sectors
Diane Fox-Hill, ESOMAR, Healthcare Conference, New York, February 2006
This paper looks at how trust, authority and science are currently 'communicated' in the pharma and other sectors. Semiotic analyses show how it is possible to leverage certain codes in order to build ...

Summary | Full Text | More Like This
Read: 77 times
Paper
13.
Building a healthcare buzz
Lydia Worthington, ESOMAR, Healthcare Conference, New York, February 2006
In this paper, BuzzMetrics review findings from analyses of online consumer buzz for two sets of promising drug therapies. The therapies with pre-approval buzz experienced an enormous increase in disc ...

Summary | Full Text | More Like This
Read: 31 times
Paper
14.
American Industry Overview: Drug Stores and Proprietary Stores
Encyclopedia of American Industries, Gale, 2006
This paper covers establishments engaged in the retail sale of prescription drugs, proprietary drugs, and non-prescription medicines and may also carry a number of related lines, such as cosmetics, to ...

Summary | Full Text | More Like This
Read: 17 times
Paper
15.
Direct-to-consumer prescription drug advertising: understanding its consequences
Jisu Huh and Lee B. Becker, International Journal of Advertising, Vol. 24, No. 4, 2005, pp.441-466
Direct-to-consumer (DTC) prescription drug advertising is one of the fastest-growing advertising categories in the USA and has generated a great deal of controversy among policy makers, physicians and ...

Summary | Full Text | More Like This
Read: 30 times
Paper
16.
Attitudes towards DTC advertising in Australia: an exploratory study
Kenneth E. Miller and David S. Waller, International Journal of Advertising, Vol. 23, No. 3, 2004, pp.389-405
In Australia direct-to-consumer (DTC) advertising of prescription medicines is currently not permitted. Despite a government report that did not recommend a change, pharmaceutical companies have conti ...

Summary | Full Text | More Like This
Read: 28 times
Paper
17.
UK physicians' attitudes towards direct-to-consumer advertising of prescription drugs: an extension and review
Dayananda Palihawadana, Graham Spickett-Jones and J.D Reast, International Journal of Advertising, Vol. 23, No. 2, 2004, pp.253-276
Since 1990 in New Zealand, and 1997 in the USA, legislation has controversially allowed brand owners to advertise prescription drugs direct to consumers (DTC), with advertising spends of approaching N ...

Summary | Full Text | More Like This
Read: 29 times
Paper
18.
Direct to consumer advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responses
John Calfee, Philip Gendall and Janet Hoek, International Journal of Advertising, Vol. 23, No. 2, 2004, pp.229-251
New Zealand and the United States are the only two advanced nations to permit direct-to-consumer advertising (DTCA) of prescription medicines, but they use very different regulatory regimes. This pape ...

Summary | Full Text | More Like This
Read: 33 times
Paper
19.
Dr. Mom and Dr. Web: A Qualitative Analysis of Women's Use of Health Information on the Web
Vandana Shankar, Liza Stavchansky and Wendy Macias, Journal of Interactive Advertising, Vol. 4, No 2, Spring 2004
The primary goal of this qualitative study was to begin to understand and gain insight into how women use the Web to search for health information. This has become an increasingly important area to un ...

Summary | Full Text | More Like This
Read: 43 times
Paper
20.
Pharmaceutical advertising in the USA: information or influence?
Bruce A Huhmann, Jennifer J Argo and Kellly J Main, International Journal of Advertising, Vol. 23, No. 1, 2004, pp.119-142
While many parts of pharmaceutical advertisements are regulated, each advertisement also contains a promotional component in which the advertiser conveys information to the consumer. The purpose of ...

Summary | Full Text | More Like This
Read: 47 times
Paper
21.
A model assessing the effectiveness of direct-to-consumer advertising: integration of concepts and measures from marketing and healthcare
Matthew Perri III, Aparna D Deshpande, Anil Menon and George M Zinkhan, International Journal of Advertising, Vol. 23, No. 1, 2004, pp.91-118
The advertising of prescription medications directly to consumers (DTC advertising) has become a familiar practice in the USA. As with all advertising spending, key questions include: how effective ...

Summary | Full Text | More Like This
Read: 54 times
Paper
22.
Prescription medication advertising: professional discomfort and potential patient benefits - can the two be balanced?
Kerry Chamberlain and Lyn Eagle, International Journal of Advertising, Vol. 23, No. 1, 2004, pp.69-90
This paper reviews current controversies surrounding direct-to-consumer (DTC) promotion of prescription drugs in an attempt to address the empirical information void and to provide a framework for s ...

Summary | Full Text | More Like This
Read: 11 times
Paper
23.
'Ask Your Doctor!' measuring the effect of direct-to-consumer communications in the world's largest healthcare market
Chris Moore, Hugh J White, L.P Draves and Roland Soong, International Journal of Advertising, Vol. 23, No. 1, 2004, pp.53-68
Money, buckets of it, is the indispensable fuel for developing a new drug from a promising molecule into a proven and government-approved contender for physician prescription. More money is required t ...

Summary | Full Text | More Like This
Read: 44 times
Classic paper - a key, timeless read
24.
The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debate
Frank Auton, International Journal of Advertising, Vol. 23, No. 1, 2004, pp.5-52
Pharmaceuticals are a substantial global industry which is unusual in that with few exceptions direct-to-consumer advertising (DTCA) is not permitted. This paper examines the arguments presented for ...

Summary | Full Text | More Like This
Read: 104 times
Paper
25.
Pharmaceutical advertising
Admap, February 2004, Issue 447, pp.13-14
This Best Practice paper looks at the issues involved in advertising pharmaceuticals, especially to Western consumers. It covers OTC (over the counter) activity for non-prescribed drugs, and DTC (dir ...

Summary | Full Text | More Like This
Read: 80 times
Paper
26.
Consumer response to print prescription drug advertising
Scott C. Purvis and Abhilasha Mehta, Journal of Advertising Research, Vol. 43, No. 2, June 2003, pp.194-206
Direct-to-consumer (DTC) prescription drug advertising has grown significantly over the last few years and extended into a variety of health conditions, even as the controversy around it continues. Ho ...

Summary | Full Text | More Like This
Read: 20 times
Paper
27.
Media and message effects on DTC prescription drug print advertising awareness
Martin S. Roth, Journal of Advertising Research, Vol. 43, No. 2, June 2003, pp.180-193
Despite various surveys of consumer attitudes toward direct-to-consumer (DTC) prescription drug advertising, little is known about the effectiveness of specific advertising campaigns. This article com ...

Summary | Full Text | More Like This
Read: 37 times
Paper
28.
Direct-to-consumer advertising for prescription pharmaceuticals: a good idea?
Roderick White, Hot Topics, June 2003
WARC Hot Topics are the essential guide to debates in and around marketing. This paper explores the key issues surrounding DTC pharma ads, with onward links to related papers on WARC and the Web.

Summary | Full Text | More Like This
Read: 20 times
Paper
29.
Video, Ergo, Agnosco
Nic Hall, ESOMAR, Consumer insights conference, Madrid, April 2003
Direct consumer contact programmes – in which people from all levels of the organisation aim to meet the ‘real people’, who use their products and services – are all the rage. It is generally accepted ...

Summary | Full Text | More Like This
Read: 6 times
Paper
30.
Segmentation beyond cultural boundaries
Mila C. Montemayor, ESOMAR, Healthcare Conference, New York, February 2003
Although the use of market segmentation analysis is standard research practice in the United States and Europe, many researchers experience difficulty when applying the same methodology to research in ...

Summary | Full Text | More Like This
Read: 87 times


1 2 Page:Next >




WARC Publications  |  WARC Conferences  |  About Us  |  Links  |  Contact Us  |  Terms & Conditions
© 2008 Copyright and Database Rights owned by WARC

  |    |  
Subjects
SEARCHStart searching...
Start an Advanced Searchall subjectsfind a case studyDigitalProduct CategoriesMarketingConsumersAdvertisingBrandsMediaData